Shorter time to diagnosis and improved stage at presentation in swiss patients with retinoblastoma treated from 1963 to 2004

OBJECTIVES. Retinoblastoma is the most frequent intraocular malignancy in children. Early diagnosis is essential for globe salvage and patient survival. The aim of our study was to determine how time to diagnosis of retino-blastoma has evolved over a 40-year period in Switzerland. METHOD AND PATIENT...

Full description

Saved in:
Bibliographic Details
Published in:Pediatrics (Evanston) 2006-11, Vol.118 (5), p.2211
Main Authors: Wallach, Marjorie, Balmer, Aubin, Munier, Francis, Houghton, Susan, Pampallona, Sandro, von der Weid, Nicolas, Beck-Popovic, Maja
Format: Article
Language:English
Subjects:
Children & youth
Diagnosis
Medical diagnosis
Medical disorders
Medical research
Patients
Pediatrics
Retinoblastoma
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:OBJECTIVES. Retinoblastoma is the most frequent intraocular malignancy in children. Early diagnosis is essential for globe salvage and patient survival. The aim of our study was to determine how time to diagnosis of retino-blastoma has evolved over a 40-year period in Switzerland. METHOD AND PATIENTS. A retrospective study of 139 Swiss patients with retinoblastoma was performed comparing 3 periods: (1) 1963-1983; (2) 1984-1993; and (3) 1994-2004. Factors taken into account were gender, laterality of retinoblastoma, age at first symptoms, type and first observer of symptoms, time to diagnosis, age at diagnosis, disease stage, and family history. RESULTS. Thirty-seven patients (26.6%) were treated in period 1, 44 (31.7%) in period 2, and 58 (41.7%) in period 3. Overall, the diagnostic interval decreased in a significant way from 6.97 months in period 1 to 3.58 in period 2 and to 2.25 in period 3. When looking separately at unilateral and bilateral disease, the decrease of the diagnostic interval remained statistically significant in unilateral retinoblastoma; there was also a significant reduction in the number of patients with advanced group E disease (Murphree classification) (61.5% in period 1, 46.7% in period 2, 22.2% in period 3). In bilateral disease, the same observations were made to a lesser extent. However, there were no cases with group E disease in l0 patients with positive family history. Leukocoria (48.2%) and strabismus (20.1%) were the 2 most frequent symptoms throughout the 3 periods. The only factors that statistically influenced the chances of having a diagnosis of group E disease were the diagnostic interval and period of diagnosis. CONCLUSIONS. Progress has been made in the diagnosis of retinoblastoma in Switzerland, notably in unilateral disease. Improvement to a lesser extent has also been observed in bilateral cases but without statistical significance. Greater effort is needed to teach physicians-in-training to recognize the importance of ocular symptoms and refer patients earlier. KEYWORDS. retinoblastoma, diagnostic interval, disease stage.
ISSN:0031-4005
1098-4275